SOUTHLAKE DIAGNOSTICS INC
NPI 1447925516
Clinical Medical Laboratory in Southlake, TX
NPI Status: Active since August 11, 2021
Contact Information
580 COMMERCE ST STE 150A
SOUTHLAKE, TX
ZIP 76092
Phone: (844) 473-9522
- Organization
- Clinical Medical Laboratory
About SOUTHLAKE DIAGNOSTICS INC
This page provides the complete NPI Profile along with additional information for Southlake Diagnostics Inc, a provider established in Southlake, Texas operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1447925516 assigned on August 2021. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 4 years ago. The authorized official of this NPI record is Donald Stables Jr. (Ceo)
- NPI
- 1447925516
- Provider Name
- SOUTHLAKE DIAGNOSTICS INC
- Entity Type
- Organization
- Location Address
- 580 COMMERCE ST STE 150A SOUTHLAKE, TX 76092
- Location Phone
- (844) 473-9522
- Mailing Address
- 580 COMMERCE ST STE 150A SOUTHLAKE, TX 76092
- Mailing Phone
- (844) 473-9522
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 08-11-2021
- Last Update Date
- 11-21-2022
- Code Navigator
Establishments like Southlake Diagnostics Inc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (covid-19)
Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (covid-19)
Screening test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) neutralizing antibody
Screening test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) neutralizing antibody
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge
This service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.
This service was performed 388 times for 51 patientsThis service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.
This service was performed 255 times for 56 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 382 times for 49 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 255 times for 56 patientsThis procedure measures the presence of neutralizing antibodies in your body against SARS-CoV-2, the virus causing COVID-19. It helps determine your immune response, indicating whether you've been exposed to the virus or how your body reacted to a COVID-19 vaccine.
This service was performed 464 times for 427 patientsThis procedure measures the presence of neutralizing antibodies in your body against SARS-CoV-2, the virus causing COVID-19. It helps determine your immune response, indicating whether you've been exposed to the virus or how your body reacted to a COVID-19 vaccine.
This service was performed 1,806 times for 1,590 patientsA screening test for COVID-19 neutralizing antibody checks for antibodies in your blood. These antibodies indicate that you've had a past infection with the virus. The test involves taking a small blood sample, which is then analyzed in a lab. It's not a test for current infection.
This service was performed 1,774 times for 1,433 patientsA screening test for COVID-19 neutralizing antibody checks for antibodies in your blood. These antibodies indicate that you've had a past infection with the virus. The test involves taking a small blood sample, which is then analyzed in a lab. It's not a test for current infection.
This service was performed 218 times for 182 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 877 times for 501 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 2,002 times for 1,581 patientsThis service involves a healthcare professional traveling to collect necessary lab samples from patients who are homebound or in a nursing home. The travel allowance is a partial charge for the trip made to facilitate this service. It ensures medical care accessibility for all, regardless of mobility.
This service was performed 1,795 times for 1,454 patientsReviews for SOUTHLAKE DIAGNOSTICS INC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1447925516, we treat the final digit (6) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 64. The final step is to find the difference between that total and the next multiple of ten (70 - 64 = 6).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 64 is 70. The difference is the calculated check digit.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1447925516, enumerated as an "organization" on August 11, 2021.
The provider is located at 580 COMMERCE ST STE 150A SOUTHLAKE, TX 76092 and the phone number is (844) 473-9522.
Clinical Medical Laboratory with taxonomy code 291U00000X.
